Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

Notes Payable (Details Narrative) - USD ($)									1 Months Ended	9 Months Ended	10 Months Ended
Notes Payable (Details Narrative) - USD ($)	Mar. 21, 2017	Mar. 13, 2017	Feb. 02, 2017	Nov. 03, 2016	Sep. 15, 2016	Mar. 31, 2016	Jun. 29, 2015	Feb. 02, 2015	Mar. 31, 2017	Sep. 30, 2017	Nov. 11, 2017	Jun. 30, 2017	May 31, 2017	Mar. 15, 2017	Mar. 07, 2017	Dec. 31, 2016	Feb. 03, 2015
Consideration received						$ 5,000,000
Estimated value of accounts receivable						$ 8,700,000
Adjustment value of debt										$ 0						$ 1,500,000
Investment percentage										20.00%
Debt term						6 months
Repayment of debt						$ 500,000
Debt instrument description						All payments recovered from the accounts receivable up to $5.25 million, if paid in full within six months, or $5.5 million, if not paid in full within six months, and (iii) 20% of all payments of the accounts receivable in excess of amounts received in (i) and (ii). On March 31, 2017, to the extent that the counterparty has not been paid $6.0 million, the Company was required to pay the difference, plus 30% interest per annum on the total balance. To date, the Company has not recovered any payments against the accounts receivable.
Accrued expenses										$ 1,900,000
Due to related party										$ 6,900,000
Debt instrument periodic payment				$ 400,000
Debt instrument maturity date										Aug. 31, 2017
Warrant to purchase common stock														2,056
Stock options exercise price per share
Loan outstanding
Accrued interest										200,000
Alcimede LLC [Member]
Debt instrument maturity date								Feb. 02, 2016
Due from related party																	$ 3,000,000
Debt instrument interest rate																	6.00%
Debt instrument extended due date								Aug. 02, 2017
Share based payment of exercised options granted							66,667
Stock options exercise price per share							$ 37.50
Loan outstanding							$ 2,500,000
Repayment of common stock							$ 300,000
Mr Lagan [Member]
Repayment of debt									$ 50,000	100,000
Debt instrument extended due date									Feb. 02, 2018
Stockholder [Member]
Repayment of debt											$ 50,000
Due to related party										$ 75,000
Mr Diamantis [Member]
Due to related party												$ 3,600,000
Debt instrument face amount															$ 3,800,000
Warrant to purchase common stock															27,667
Warrant exercise per share															$ 15.00
Debt instrument interest rate												10.00%	10.00%
TCA Debenture [Member]
Repayment of debt	$ 750,000
Accrued and unpaid interest	100,000		$ 400,000
Debt instrument fee	$ 150,000
Debt instrument maturity date	Jun. 27, 2017
TCA Debenture [Member] \| April 2017 Through September 2017 [Member]
Debt instrument periodic payment	$ 2,600,000
September 2016 Notes [Member]
Debt instrument maturity date					Mar. 15, 2017
Debt instrument conversion price					$ 112.50
Warrant to purchase common stock					4,444
Warrant exercise per share					$ 180.00
Warrant exchanged shares of common stock		26,667
September 2016 Notes [Member] \| Two Investor [Member]
Debt instrument face amount					$ 400,000